A Bio-processing Strategy for Full utilization of Sea cucumbers for Production of High Value Nutraceuticals and Pharmaceuticals

充分利用海参生产高价值保健品和药品的生物加工策略

基本信息

  • 批准号:
    RGPIN-2015-06121
  • 负责人:
  • 金额:
    $ 1.6万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Discovery Grants Program - Individual
  • 财政年份:
    2018
  • 资助国家:
    加拿大
  • 起止时间:
    2018-01-01 至 2019-12-31
  • 项目状态:
    已结题

项目摘要

Sea cucumbers are found in both benthic areas and deep seas and have been used as a source of food and drug for decades. There are around 1500 sea cucumber species found in ocean forming 90% of total seabed biomass. They are used to treat cancer, arthritis and intestinal and urinal dysfunctions and can lead to increase in immune system. Sea cucumbers also possess a number of biological activities including anti-angiogenic, anticancer, anticoagulant, anti-hypertension, anti-inflammatory, antimicrobial, antioxidant, antithrombotic, antitumor and wound healing properties. In Canada, commercial sea cucumber fisheries were initiated in 2003 with an allocation of 454 tons which increased to 2242 tons in 2013. The most common sea cucumber species found in Atlantic Canada is C. frondosa. Sea cucumbers comprise body wall, gonads, respiratory tract, flower and skin. Sea cucumber are composed of high value profile of vitamins and minerals. Sea cucumber also contains various essential high value nutraceuticals and pharmaceuticals with various biological properties including: collagen, gelatin, protein, amino acids, omega-3 fatty acids, glycosoaminoglycans (GAGs), chondroitin sulfate (fucosylated), triterpene glycosides (saponin), sulfated triterpene glycosides, lectin, sulfated polysaccharides, sterols, phenols, flavonoids, triterpene oligoglycosides, glycoprotein, steroidal sapogenins and mucopolysaccharides. Limited scientific research has so far been carried out on various species of sea cucumber and not much research has been done on Atlantic species. The emerging fishery in Atlantic Canada is currently facing economic and environmental issues which necessitated the need for the development of bioprocessing strategy for the production of various high value nutraceuticals and pharmaceuticals from sea cucumber to improve the sustainability of sea cucumber fisheries, economics of value added products and produce functional foods for specific applications. The proposed research will focus on implementation of bioprocessing strategy for full utilization of sea cucumbers for production of nutraceuticals and pharmaceuticals. The work consists of (a) development of environmentally friendly processes for the extraction of high value products including: collagen, gelatin, chondroitin sulfate and phenols and flavonoids (b) determination of the quality of the extracted products and (c) evaluate the sustainability and economic potential of the sea cucumber bioprocessing strategy. Highly qualified personnel (graduate and undergraduate students) will be trained in the fields of functional foods, biotechnology, nutraceuticals and pharmaceuticals.
海参在底栖区和深海都有发现,几十年来一直被用作食物和药物的来源。海洋中大约有1500种海参,占海底总生物量的90%。它们被用来治疗癌症、关节炎、肠道和小便功能障碍,并可导致免疫系统的增强。海参还具有抗血管生成、抗癌、抗凝、降压、抗炎、抗菌、抗氧化、抗血栓、抗肿瘤和伤口愈合等多种生物活性。在加拿大,商业海参捕捞始于2003年,分配量为454吨,2013年增加到2242吨。在加拿大大西洋最常见的海参品种是C. frondosa。海参包括体壁、生殖腺、呼吸道、花和皮肤。海参含有高价值的维生素和矿物质。海参还含有多种必需的高价值营养品和具有多种生物特性的药物,包括:胶原蛋白、明胶、蛋白质、氨基酸、omega-3脂肪酸、糖氨基聚糖(GAGs)、硫酸软骨素(集中)、三萜苷(皂素)、硫酸三萜苷、凝集素、硫酸多糖、甾醇、酚类、黄酮类、三萜低聚糖苷、糖蛋白、甾体皂苷和粘多糖。迄今为止,对各种海参进行的科学研究有限,对大西洋海参的研究还不多。加拿大大西洋地区的新兴渔业目前面临着经济和环境问题,这就需要发展生物加工战略,以生产各种高价值的营养保健品和海参药品,以提高海参渔业的可持续性,增加产品的经济性,并为特定应用生产功能性食品。本研究的重点是实施生物加工策略,以充分利用海参生产保健品和药品。这项工作包括(a)开发提取高价值产品的环保工艺,包括:胶原蛋白、明胶、硫酸软骨素、酚类和类黄酮;(b)测定提取产品的质量;(c)评估海参生物加工策略的可持续性和经济潜力。将在功能食品、生物技术、营养食品和药品等领域培养高素质人才(研究生和本科生)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dave, Deepika其他文献

Antioxidant and ACE-Inhibitory Activity of Protein Hydrolysates Produced from Atlantic Sea Cucumber (Cucumaria frondosa).
  • DOI:
    10.3390/molecules28135263
  • 发表时间:
    2023-07-07
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Senadheera, Tharindu R. L.;Hossain, Abul;Dave, Deepika;Shahidi, Fereidoon
  • 通讯作者:
    Shahidi, Fereidoon
Antioxidant potential and physicochemical properties of protein hydrolysates from body parts of North Atlantic sea cucumber (Cucumaria frondosa)
  • DOI:
    10.1186/s43014-020-00049-3
  • 发表时间:
    2021-02-01
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Senadheera, Tharindu R. L.;Dave, Deepika;Shahidi, Fereidoon
  • 通讯作者:
    Shahidi, Fereidoon
Production of High Quality Fish Oil by Enzymatic Protein Hydrolysis from Cultured Atlantic Salmon By-Products: Investigation on Effect of Various Extraction Parameters Using Central Composite Rotatable Design
  • DOI:
    10.1007/s12649-017-9998-6
  • 发表时间:
    2018-11-01
  • 期刊:
  • 影响因子:
    3.2
  • 作者:
    Routray, Winny;Dave, Deepika;Murphy, Wade
  • 通讯作者:
    Murphy, Wade
Effect of Drying on Nutritional Composition of Atlantic Sea Cucumber (Cucumaria frondosa) Viscera Derived from Newfoundland Fisheries
  • DOI:
    10.3390/pr9040703
  • 发表时间:
    2021-04-01
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Liu, Yi;Dave, Deepika;Murphy, Wade
  • 通讯作者:
    Murphy, Wade
Lipid class and fatty acid composition of oil extracted from Atlantic salmon by-products under different optimization parameters of enzymatic hydrolysis

Dave, Deepika的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dave, Deepika', 18)}}的其他基金

A Bio-processing Strategy for Full utilization of Sea cucumbers for Production of High Value Nutraceuticals and Pharmaceuticals
充分利用海参生产高价值保健品和药品的生物加工策略
  • 批准号:
    RGPIN-2015-06121
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Discovery Grants Program - Individual
A Bio-processing Strategy for Full utilization of Sea cucumbers for Production of High Value Nutraceuticals and Pharmaceuticals
充分利用海参生产高价值保健品和药品的生物加工策略
  • 批准号:
    RGPIN-2015-06121
  • 财政年份:
    2021
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Discovery Grants Program - Individual
A Bio-processing Strategy for Full utilization of Sea cucumbers for Production of High Value Nutraceuticals and Pharmaceuticals
充分利用海参生产高价值保健品和药品的生物加工策略
  • 批准号:
    RGPIN-2015-06121
  • 财政年份:
    2019
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Discovery Grants Program - Individual
Development of innovative drying technology for optimized product value of sea cucumber
开发创新干燥技术以优化海参产品价值
  • 批准号:
    528750-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Engage Grants Program
A Bio-processing Strategy for Full utilization of Sea cucumbers for Production of High Value Nutraceuticals and Pharmaceuticals
充分利用海参生产高价值保健品和药品的生物加工策略
  • 批准号:
    RGPIN-2015-06121
  • 财政年份:
    2017
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Discovery Grants Program - Individual
A Bio-processing Strategy for Full utilization of Sea cucumbers for Production of High Value Nutraceuticals and Pharmaceuticals
充分利用海参生产高价值保健品和药品的生物加工策略
  • 批准号:
    RGPIN-2015-06121
  • 财政年份:
    2016
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Discovery Grants Program - Individual
A Bio-processing Strategy for Full utilization of Sea cucumbers for Production of High Value Nutraceuticals and Pharmaceuticals
充分利用海参生产高价值保健品和药品的生物加工策略
  • 批准号:
    RGPIN-2015-06121
  • 财政年份:
    2015
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Discovery Grants Program - Individual

相似国自然基金

Sirt1通过调控Gli3 processing维持SHH信号促进髓母细胞瘤的发展及机制研究
  • 批准号:
    82373900
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
靶向Gli3 processing调控Shh信号通路的新型抑制剂治疗儿童髓母细胞瘤及相关作用机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
超高频超宽带系统射频基带补偿理论与技术的研究
  • 批准号:
    61001097
  • 批准年份:
    2010
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
堆栈型全光缓存研究
  • 批准号:
    60977003
  • 批准年份:
    2009
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
转录调控中起作用的细胞周期激酶的鉴定及其作用机制研究
  • 批准号:
    30970625
  • 批准年份:
    2009
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目
非负矩阵分解及在盲信号处理中的应用
  • 批准号:
    60874061
  • 批准年份:
    2008
  • 资助金额:
    32.0 万元
  • 项目类别:
    面上项目
1A6/DRIM与NIR的相互作用及对NIR的功能调节
  • 批准号:
    30771224
  • 批准年份:
    2007
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Consultative Physical Therapy: A Physical Activity and Exercise Implementation Strategy in Parkinson's
咨询物理治疗:帕金森病的身体活动和锻炼实施策略
  • 批准号:
    10565287
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
Research on Automated Formative Feedback of Problem-Solving Strategy Writing in Introductory Physics using Natural Language Processing
利用自然语言处理的物理导论中解题策略写作的自动形成反馈研究
  • 批准号:
    2300645
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Standard Grant
A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates
识别酪氨酸磷酸酶底物的通用光交联策略
  • 批准号:
    10612641
  • 财政年份:
    2023
  • 资助金额:
    $ 1.6万
  • 项目类别:
Changes in visual processing strategy: effects of context, task, and training
视觉处理策略的变化:环境、任务和训练的影响
  • 批准号:
    RGPIN-2022-04216
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Discovery Grants Program - Individual
Changes in visual processing strategy: effects of context, task, and training
视觉处理策略的变化:环境、任务和训练的影响
  • 批准号:
    DGECR-2022-00283
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Discovery Launch Supplement
MWAS+ – A Novel Drug Repurposing Strategy for ADRD Prevention
MWAS — 预防 ADRD 的新型药物再利用策略
  • 批准号:
    10446705
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
ADDRESSING THE CONTINUING CHALLENGE OF IDENTIFYING AND MANAGING CORONARY RISK: A PERSON-SPECIFIC STRATEGY USING PROTEOMICS
应对识别和管理冠状动脉风险的持续挑战:利用蛋白质组学的个体化策略
  • 批准号:
    10549983
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations
探索突触/突触外 NMDAR 平衡的调节作为阿尔茨海默病和其他神经退行性疾病的新型治疗策略
  • 批准号:
    10655316
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
MWAS+ – A Novel Drug Repurposing Strategy for ADRD Prevention
MWAS — 预防 ADRD 的新型药物再利用策略
  • 批准号:
    10677666
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
Exploring the modulation of synaptic/extrasynaptic NMDAR balance as a novel therapeutic strategy in Alzheimer's disease and other neurodegenerations
探索突触/突触外 NMDAR 平衡的调节作为阿尔茨海默病和其他神经退行性疾病的新型治疗策略
  • 批准号:
    10427332
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了